The Role of <sup>18</sup>F-FDG PET/CT and MRI in Assessing Pathological Complete Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer: A Systematic Review and Meta-Analysis

<div>Forest plot of the <sup>18</sup>F-FDG PET/CT of 6 included studies. The size of the square plotting reflects the study weight. Horizontal lines are the 95% confidence intervals.</div>

BioMed Research International

fig3

Figure 3

Figure 3: The Role of <sup>18</sup>F-FDG PET/CT and MRI in Assessing Pathological Complete Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer: A Systematic Review and Meta-Analysis 

Figure 3 | The Role of 18F-FDG PET/CT and MRI in Assessing Pathological Complete Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer: A Systematic Review and Meta-Analysis 